Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000031

Chief Scientific Officer sold 3,961 shares at $18.00 ($71,316)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2023-04-17 Sale 10b5-1 −3,961 $18.00 $71,316 171,325 D
Open-market sales · 3,961 sh · avg $18.00 · $71,316
Loading xslF345X04/wf-form4_168194195395803.xml…